- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Antibody Production
- Protein Production
- Protein Characterization
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Sustainability
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- SustainabilityAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Scientific Poster Download
Poster modified on 17/10/2023
Overcoming Technical Challenges with BsAbs and MsAbs Using Novel Technology Platforms
Jianqing Xu, Shuang Wang, Xinzhao Fan, George Wang, Jijie Gu, and Siwei Nie
WuXi Biologics, No. 299 Fute Zhong Road, Pudong New District, Shanghai, China
WuXiBody® is an industry-leading proprietary bsAb and msAb platform. Here we present comprehensive technical data to illustrate the flexibility, universality and developability characteristics of the WuXiBody platform, and provide a case study demonstrating good in vitro and in vivo efficacy of WuXiBody-derived bsAb.
This scientific poster was originally presented during the 2023 Chinese Antibody Society Conference
Discuss This Poster
To discuss the data in this poster, please complete the form on the following page to connect with our experts.